Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001280021 | SCV001642747 | likely benign | Wilson disease | 2023-12-14 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV001507827 | SCV001713639 | uncertain significance | not provided | 2020-06-17 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001280021 | SCV001977191 | uncertain significance | Wilson disease | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001507827 | SCV001999011 | uncertain significance | not provided | 2019-09-11 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge |
Natera, |
RCV001280021 | SCV001467167 | uncertain significance | Wilson disease | 2020-04-15 | no assertion criteria provided | clinical testing |